You have 9 free searches left this month | for more free features.

Tumor necrosis factor-α (TNF-α)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

GCF PLAP-1, Sclerostin and TNF-a Levels in Periodontitis

Completed
  • Periodontitis
  • Periodontal clinical measurements and GCF sampling
  • Aydın, Turkey
    Adnan Menderes University, Faculty of Dentistry, Department of P
Dec 8, 2022

Therapeutic Drug Monitoring and Serum TNFa Levels in Pediatric

Completed
  • Acute Graft-versus-host Disease
    • Trieste, Italy
      IRCCS Burlo Garofolo
    Apr 11, 2023

    Periimplant Soft Tissue Phenotype on Marginal Bone Loss

    Completed
    • Alveolar Bone Loss
    • +2 more
    • Nuclear Factor-Kappa B Ligand (RANKL) analysis
    • +4 more
    • Konya, Turkey
      Necmettin Erbakan University, dentistry Faculty
    Jan 24, 2023

    Rates of Dementia and Alzheimer's Disease in Participants

    Completed
    • Dementia
    • Alzheimer Disease
    • Titusville, New Jersey
      Janssen R&D
    Oct 15, 2021

    Pediatric HSCT Recipients With aGVHD: Prospective Observational

    Recruiting
    • Graft Versus Host Disease, Acute
    • Hematopoietic Stem Cell Transplantation
      • Trieste, Italy
        IRCCS Burlo Garofolo
      Apr 30, 2022

      IBD, Biological Substance; Adverse Effect Trial in Haifa (Azithromycin Pill, Placebo)

      Not yet recruiting
      • Inflammatory Bowel Diseases
      • Biological Substance; Adverse Effect
      • Azithromycin Pill
      • Placebo
      • Haifa, Israel
        Rambam Health Care Campus
      Oct 25, 2022

      Acute Gout Trial in Nanchang (rhTNFR-Fc, Triamcinolone Acetonide)

      Not yet recruiting
      • Acute Gout
      • Nanchang, Jiangxi, China
        Department of Rheumatology and Clinical Immunology, Jiangxi Prov
      Jun 28, 2023

      Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)

      Not yet recruiting
      • Castration-Resistant Prostate Carcinoma
      • Prostate Adenocarcinoma
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jul 20, 2023

      Lumbar Disc Herniation Trial in Bani Suwayf (Radiofrequency pulsed mode on dorsal root ganglion combined with transforaminal

      Completed
      • Lumbar Disc Herniation
      • Radiofrequency pulsed mode on dorsal root ganglion combined with transforaminal steroids injection
      • Transforaminal injection of Steroids alone
      • Banī Suwayf, Beni-Suef, Egypt
      • +1 more
      Dec 11, 2022

      Solid Tumor Trial (Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T), Tumor necrosis factor-thymosin alfa 1 recombinant

      Completed
      • Solid Tumor
      • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T)
      • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T) and chemotherapy
      • (no location specified)
      Jun 8, 2023

      Cardiac Functions in Type 1 Diabetes Mellitus

      Not yet recruiting
      • Diabetes Mellitus, Type 1
      • +2 more
      • transthoracic echocardiography
      • (no location specified)
      Nov 12, 2023

      Tumor Necrosis Factor-alpha Antagonists in Rheumatoid Arthritis.

      Recruiting
      • Rheumatoid Arthritis
      • +2 more
      • Infliximab: Adalimumab; Etanercept;
      • Sulaymaniyah, Kurdistan Region, Iraq
        Hiwa Khidhir Saaed
      May 12, 2022

      Janus Kinase Inhibitors Vs Tumor Necrosis Factor Inhibitors in

      Not yet recruiting
      • Rheumatoid Arthritis
      • Observation
      • (no location specified)
      Oct 8, 2022

      HLA-DQA1*05 Genotype in Anti-TNF Treatment With Proactive

      Recruiting
      • Drug Monitoring
      • Inflammatory Bowel Diseases
      • Tumor necrosis factor (TNF)-alpha inhibitors
      • Valladolid, Spain
        Hospital Universitario Rio Hortega
      Aug 8, 2023

      Psoriasis Vulgaris Trial in Surabaya (Lactobacillus Plantarum IS-10506, Placebo)

      Recruiting
      • Psoriasis Vulgaris
      • Lactobacillus Plantarum IS-10506
      • Placebo
      • Surabaya, Jawa Timur, Indonesia
        Universitas Airlangga
      Feb 15, 2022

      Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier

      Completed
      • Arthritis Rheumatoid
      • New York, New York
        Pfizer
      Jun 8, 2022

      Colitis,Ulcerative Trial in Norway (Discontinuation of anti-TNF treatment, Continuation of anti-TNF treatment)

      Active, not recruiting
      • Colitis,Ulcerative
      • Discontinuation of anti-TNF treatment
      • Continuation of anti-TNF treatment
      • Alesund, Norway
      • +18 more
      Jul 13, 2022

      Inflammatory Response, Cardiac Disease Trial (Colchicine 0.5 MG, Placebo)

      Not yet recruiting
      • Inflammatory Response
      • Cardiac Disease
      • Colchicine 0.5 MG
      • Placebo
      • (no location specified)
      Nov 1, 2023

      Neuromyelitis Optica Spectrum Disorders, Pain Trial in Guangzhou (electroacupuncture)

      Completed
      • Neuromyelitis Optica Spectrum Disorders
      • Pain
      • electroacupuncture
      • Guangzhou, Guangdong, China
        Guangdong Provincial Hospital of Chinese Medicine
      May 20, 2023

      Immunogenicity of TNF Inhibitors in Arthritis Poorer Treatment

      Recruiting
      • Arthritis, Rheumatoid
      • +2 more
        • Aalborg, Denmark
          Department of rheumatology
        Sep 1, 2022

        Diabetic Foot Ulcer Trial in Jakarta Pusat, Jakarta (LL37, Standard Wound Care)

        Unknown status
        • Diabetic Foot Ulcer
        • LL37
        • Standard Wound Care
        • Jakarta Pusat, DKI Jakarta, Indonesia
        • +2 more
        Sep 22, 2019

        HIV Trial in Honolulu, New York, Cleveland (Tumor Necrosis Factor soluble receptor-immunoadhesin complex)

        Completed
        • HIV Infections
        • Tumor Necrosis Factor soluble receptor-immunoadhesin complex
        • Honolulu, Hawaii
        • +2 more
        Oct 28, 2021

        Recurrent Unexplained Implantation Failure Trial (Certolizumab (CIMZIA® ; TNF-a antagonist), Placebo (NaCl 0.9 % solution))

        Not yet recruiting
        • Recurrent Unexplained Implantation Failure
        • Certolizumab (CIMZIA® ; TNF-α antagonist)
        • Placebo (NaCl 0.9 % solution)
        • (no location specified)
        Jun 30, 2023

        Advanced Breast Cancer Trial in Poland, Turkey (Plasma soluble TNF receptor pulldown, Plasma soluble TNF receptor pulldown +

        Recruiting
        • Advanced Breast Cancer
        • Plasma soluble TNF receptor pulldown
        • +2 more
        • Kraków, Małopolskie, Poland
        • +4 more
        Mar 9, 2022

        Gulf War Illness Trial in Davie, Miami (Etanercept, Mifepristone)

        Recruiting
        • Gulf War Illness
        • Davie, Florida
        • +1 more
        May 9, 2022